Snowball logo
logo
SLNO

Soleno Therapeutics Inc

SLNO β€’ NASDAQ
$53.01$0.00Β  (0%)

Frequently asked questions

What sector does Soleno Therapeutics Inc (SLNO) operate in?

Soleno Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Soleno Therapeutics Inc (SLNO) current stock price?

As of the latest data, Soleno Therapeutics Inc stock price is $53.01, with a previous close of $53.01.

What is Soleno Therapeutics Inc (SLNO) current market capitalization?

Soleno Therapeutics Inc market cap is approximately 2.76 billion.

What is Soleno Therapeutics Inc (SLNO) Earnings Per Share (EPS)?

The trailing EPS is $1.93, and the forward EPS is $6.06.

What is Soleno Therapeutics Inc (SLNO) Price-to-Earnings (P/E) ratio?

Soleno Therapeutics Inc current P/E ratio is 27.47, with a forward P/E of 8.75.

What is Soleno Therapeutics Inc (SLNO) EBITDA?

Soleno Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 36.72 million.

Does Soleno Therapeutics Inc (SLNO) pay dividends?

No. Soleno Therapeutics Inc does not pay a dividend.

How did Soleno Therapeutics Inc (SLNO) perform in its most recent earnings report?

In the last report (March 31, 2026), Soleno Therapeutics Inc posted an EPS surprise of -13.24% and a revenue surprise of 0.91%.

What is Soleno Therapeutics Inc (SLNO) beta (volatility) score?

Soleno Therapeutics Inc has a beta of -2.217, indicating lower volatility than the overall market.